Xtant Medical Holdings, Inc. (XMS.F)
| Previous close | 0.8150 |
| Open | 0.8250 |
| Bid | 0.8600 x 0 |
| Ask | 0.8900 x 0 |
| Day's range | 0.8250 - 0.8250 |
| 52-week range | 0.5500 - 1.2800 |
| Volume | |
| Avg. volume | 296 |
| Market cap | 115.314M |
| Beta (5Y monthly) | 0.22 |
| PE ratio (TTM) | 82.50 |
| EPS (TTM) | 0.0100 |
| Earnings date | 02 May 2024 - 06 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Insider MonkeyXtant Medical Holdings, Inc. (AMEX:XTNT) Q4 2023 Earnings Call Transcript
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q4 2023 Earnings Call Transcript April 1, 2024 Xtant Medical Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.03 EPS, expectations were $-0.025. Xtant Medical Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). […]
- Thomson Reuters StreetEvents
Q4 2023 Xtant Medical Holdings Inc Earnings Call
Q4 2023 Xtant Medical Holdings Inc Earnings Call
GlobeNewswireXtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Establishes Full Year 2024 Revenue Guidance of $112 Million - $116 Million BELGRADE, Mont., April 01, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended December 31, 2023. “2023 was a transformative year for Xtant Medical. We achieved record annual revenues of $91.3 million, up 58% y
